The National Medical Products Administration (NMPA) has granted marketing approval for Pulnovo Medical’s disposable circular pulmonary artery radiofrequency ablation catheter, marking it as a novel product in the medical device landscape.
This innovative catheter employs a puncture intervention technique to access the bloodstream, targeting pulmonary arterial hypertension by disrupting the sympathetic nervous system. It is designed as an auxiliary treatment for adult patients under 70 years old suffering from idiopathic pulmonary hypertension, pulmonary hypertension related to congenital heart disease, and pulmonary hypertension associated with connective tissue diseases, particularly those who have not responded to drug therapies.- Flcube.com
